• Treatment of non-muscle invasive bladder cancer
  • The EAU approach to non-muscle invasive bladder cancer treatment
  • A single chemotherapy dose for all but high progression risk patients
  • Further chemotherapy or long-term BCG treatment for intermediate-risk patients
  • TURBT and then some
  • References
  • About Mitomycin-C Kyowa
  • Mechanism of Action
  • Solubility
  • Stability
  • Dosage, indication & side effects
  • Useful links
  1. Top >
  2. for Healthcare Professionals >
  3. References

Treatment of non-muscle invasive bladder cancer

References

1. Babjuk M et al. European Association of Urology. Guidelines on Non-muscle invasive Bladder Cancer (TaT1 and CIS)
2. Sylvester RJ et al. J Urol 2004; 171: 2186-90.
3. Kaasinen E et al. Eur Urol 2002; 42: 167-74.
4. Friedrich MG et al. Eur Urol 2007; 52: 1123-30.
5. Malmstrőm P-U et al. Eur Urol 2009; 56: 247-56.